Showing results 1 to 20 of 34
next >
| Issue Date | Title | Author(s) |
| 2020-10 | A Multicomponent Nonpharmacological Intervention to Prevent Delirium for Hospitalized People with Advanced Cancer: A Phase II Cluster Randomized Waitlist Controlled Trial (The PRESERVE Pilot Study). | Hosie, A; Phillips, J; Lam, L; Kochovska, S; Noble, B; Brassil, M; Kurrle, S; Cumming, A; Caplan, GA; Chye, R; Ely, EW; Lawlor, PG; Bush, SH; Davis, JM; Lovell, M; Parr, C; Williams, S; Hauser, K; McArdle, S; Jacquier, K; Phillipson, C; Kuwahata, L; Kerfoot, J; Brown, L; Fazekas, B; Cheah, SL; Edwards, L; Green, A; Hunt, J; Attwood, R; Assen, T; Garcia, M; Wilcock, J; Agar, M |
| 2021-01-28 | A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer | Currow, DC; Glare, P; Louw, S; Martin, P; Clark, K; Fazekas, B; Agar, MR |
| 2020-05 | A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids. | Currow, DC; Clark, K; Louw, S; Fazekas, B; Greene, A; Sanderson, CR |
| 2020-01 | Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7). | King, MT; Agar, M; Currow, DC; Hardy, J; Fazekas, B; McCaffrey, N |
| 2012-10-01 | Can assessing caregiver needs and activating community networks improve caregiver-defined outcomes? A single-blind, quasi-experimental pilot study: Community facilitator pilot | Greene, A; Aranda, S; Tieman, JJ; Fazekas, B; Currow, DC |
| 2013-12-01 | Can the LANSS scale be used to classify pain in chronic cancer pain trials? | Hardy, J; Quinn, S; Fazekas, B; Agar, M; Currow, D |
| 2019-01-01 | Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration | Matsuoka, H; Allingham, S; Fazekas, B; Brown, L; Vandersman, Z; Clark, K; Agar, MR; Currow, DC |
| 2020-03-01 | Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled Trial | Ferreira, DH; Louw, S; McCloud, P; Fazekas, B; McDonald, CF; Agar, MR; Clark, K; McCaffrey, N; Ekström, M; Currow, DC |
| 2021-01-01 | Defining the trials nurses’ role in operationalising a medicinal cannabis clinical trial | Razmovski-Naumovski, V; West, PA; Bellemore, F; Byfieldt, N; Bellamy, D; Chye, R; Clark, K; Martin, JH; Fazekas, B; Phillips, JL; Agar, MR |
| 2019-01-01 | Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain | McCaffrey, N; Flint, T; Kaambwa, B; Fazekas, B; Rowett, D; Currow, DC; Hardy, J; Agar, MR; Quinn, S; Eckermann, S |
| 2022-11-22 | Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial. | Ekström, M; Ferreira, D; Chang, S; Louw, S; Johnson, MJ; Eckert, DJ; Fazekas, B; Clark, KJ; Agar, MR; Currow, DC; Australian National Palliative Care Clinical Studies Collaborative, |
| 2017 | Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care A Randomized Clinical Trial | Agar, M; Lawlor, P; Quinn, S; Draper, B; Caplan, G; Rowett, D; Sanderson, C; Hardy, J; Le, B; Eckermann, S; McCaffrey, N; Devilee, L; Fazekas, B; Hill, M; Currow, D |
| 2020-10 | Evaluation of the IMPACCT Rapid Program: A Cross-Sectional Survey of International Site Investigators. | Hunt, J; Brown, L; Fazekas, B; Doogue, M; Rowett, D; Luckett, T; Morgan, D; Reed-Cox, K; Sheehan, C; Tuffin, P; Currow, DC |
| 2019-09-01 | Harms From Haloperidol for Symptom Management in Palliative Care—a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort Studies | Matsuoka, H; Agar, M; Vandersman, Z; Good, P; Fazekas, B; Brown, L; Hardy, J; Weil, J; Currow, DC |
| 2020-10-31 | Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide. | McCaffrey, N; Asser, T; Fazekas, B; Muircroft, W; Agar, M; Clark, K; Eckermann, S; Lee, J; Joshi, R; Allcroft, P; Sheehan, C; Currow, DC |
| 2016-04-01 | How Accurately Do Consecutive Cohort Audits Predict Phase III Multisite Clinical Trial Recruitment in Palliative Care? | McCaffrey, N; Fazekas, B; Cutri, N; Currow, DC |
| 2023-02-21 | Lidocaine for Neuropathic Cancer Pain (LiCPain): study protocol for a mixed-methods pilot study. | Lee, J; Currow, D; Lovell, M; Phillips, JL; McLachlan, A; Ritchie, M; Brown, L; Fazekas, B; Aggarwal, R; Seah, D; Sheehan, C; Chye, R; Noble, B; McCaffrey, N; Aggarwal, G; George, R; Kow, M; Ayoub, C; Linton, A; Sanderson, C; Mittal, D; Rao, A; Prael, G; Urban, K; Vandersman, P; Agar, M |
| 2019-12-01 | Low agreement between mMRC rated by patients and clinicians: Implications for practice | Ekström, M; Chang, S; Johnson, MJ; Fazekas, B; Kochovska, S; Huang, C; Currow, DC |
| 2019-01-01 | Multicomponent non-pharmacological intervention to prevent delirium for hospitalised people with advanced cancer: Study protocol for a phase II cluster randomised controlled trial | Hosie, A; Phillips, J; Lam, L; Kochovska, S; Noble, B; Brassil, M; Kurrle, SE; Cumming, A; Caplan, GA; Chye, R; Le, B; Ely, EW; Lawlor, PG; Bush, SH; Davis, JM; Lovell, M; Brown, L; Fazekas, B; Cheah, SL; Edwards, L; Agar, M |
| 2020 | No excess harms from sustained-release morphine: a randomised placebo-controlled trial in chronic breathlessness. | Johnson, MJ; Sbizzera, I; Fairhurst, C; Fazekas, B; Agar, M; Ekstrom, M; Currow, DC |
